A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD) (NCT02130362)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (148 Sites)

Showing the first 25 of 148 sites.

• Univ Alabama, Birmingham CCC /ID# 146060 — Birmingham, Alabama
• University of South Alabama /ID# 137255 — Mobile, Alabama
• Phoenix Children's Hospital /ID# 141336 — Phoenix, Arizona
• Children's Hospital Los Angeles /ID# 141551 — Los Angeles, California
• Private practice: Dr. Shervin Rabizadeh /ID# 137269 — Los Angeles, California
• Rady Children's Hospital San Diego /ID# 140883 — San Diego, California
• Univ California, San Francisco /ID# 141312 — San Francisco, California
• Children's Hospital Colorado - Aurora /ID# 137261 — Aurora, Colorado
• Connecticut Children's Medical Center - Hartford /ID# 137265 — Hartford, Connecticut
• Yale University School of Medicine /ID# 137257 — New Haven, Connecticut
• Nemours Children's Health System /ID# 148498 — Jacksonville, Florida
• University of Miami /ID# 140893 — Miami, Florida
• Winship Cancer Institute of Emory University /ID# 144274 — Atlanta, Georgia
• Children's Ctr Digestive, US /ID# 144625 — Atlanta, Georgia
• Children's Hospital New Orleans /ID# 144477 — New Orleans, Louisiana
• Maine Medical Partners /ID# 147685 — Portland, Maine
• Tufts Medical Center /ID# 143581 — Boston, Massachusetts
• Massachusetts General Hospital /ID# 141552 — Boston, Massachusetts
• Boston Children's Hospital /ID# 164102 — Boston, Massachusetts
• Duplicate_UMass Chan Medical School /ID# 148325 — Worcester, Massachusetts
• M Health Fairview University of Minnesota Medical Center - East Bank /ID# 137238 — Minneapolis, Minnesota
• Mayo Clinic - Rochester /ID# 149245 — Rochester, Minnesota
• Univ of Mississippi Med Ctr,US /ID# 137239 — Jackson, Mississippi
• Goryeb Children's Hospital /ID# 144275 — Morristown, New Jersey
• Women and Childrens Hosp /ID# 143778 — Buffalo, New York

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Crohn's Disease

• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Birmingham, Alabama
• A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. — Sun City, Arizona
• Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice. — Blacktown, New South Wales
• Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients — San Francisco, California
• Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis — Boston, Massachusetts

Explore by condition: All Crohn's Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.